Latest Articles
New scholarship to deliver 100 endometriosis nurses to regional, rural and remote areas - ANMJ
New scholarship to deliver 100 endometriosis nurses to regional, rural and remote areas ANMJ
Published: May 13, 2024, 7 a.m.
Olivia Munn, 43, reveals she had a hysterectomy during her battle with breast cancer: 'I had a real breakdown' - Daily Mail
Olivia Munn, 43, reveals she had a hysterectomy during her battle with breast cancer: 'I had a real breakdown' Daily Mail
Published: May 12, 2024, 7 a.m.
Emma Barnett: ‘The pain was so bad, I was losing the will to live’ - The Times
Emma Barnett: ‘The pain was so bad, I was losing the will to live’ The Times
Published: May 10, 2024, 7 a.m.
Radio interview with Minister Butler and Michael Rowland, ABC News Breakfast - 10 May 2024 - Department of Health
Radio interview with Minister Butler and Michael Rowland, ABC News Breakfast - 10 May 2024 Department of Health
Published: May 10, 2024, 7 a.m.
Living With Endometriosis: a Personal Perspective; a Professional Passion - Yale School of Medicine
Living With Endometriosis: a Personal Perspective; a Professional Passion Yale School of Medicine
Published: May 9, 2024, 7 a.m.
Delaware County woman has her miracle baby at 43 after medical setbacks: "I'm so blessed" - CBS News
Delaware County woman has her miracle baby at 43 after medical setbacks: "I'm so blessed" CBS News
Published: May 9, 2024, 7 a.m.
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer - AJMC.com Managed Markets Network
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer AJMC.com Managed Markets Network
Published: May 9, 2024, 7 a.m.
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer - FiercePharma
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer FiercePharma
Published: May 9, 2024, 7 a.m.
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint - Healio
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint Healio
Published: May 9, 2024, 7 a.m.
Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop - BioSpace
Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop BioSpace
Published: May 9, 2024, 7 a.m.
Link copied to clipboard!